JUST IN: NYC's disgraced 'Covid czar' Jay Varma admits Mpox 'not a problem' for US, drug 'only considered experimental'

"It’s only primarily transmitted among gay men. It basically got into the sexual networks of gay men, and a lot of gay men have tons and tons of sexual partners and often don’t use condoms."

ADVERTISEMENT

"It’s only primarily transmitted among gay men. It basically got into the sexual networks of gay men, and a lot of gay men have tons and tons of sexual partners and often don’t use condoms."

Image
Libby Emmons Brooklyn NY
ADVERTISEMENT
Another bombshell report from Steven Crowder's Mug Club Investigations shows Dr. Jay Varma, disgraced NYC Covid czar under Mayor Bill de Blasio, who hosted sex parties while requiring New Yorkers to stay home, practice social distancing, and mandated the vaccine, shows that post Covid, he continued to mislead the public in his new job. He has since been fired from that position.

The investigation reveals not only Varma's role but the way that pharmaceutical companies attempt to game the system to get their drugs approved and out into the marketplace even if they are not entirely sure of their efficacy themselves.



Crowder details that Varma was hired by pharmaceutical company Siga Tech to help sell an "antiproxviral" for monkeypox, which was later renamed Mpox due to World Health Organization concerns that having "monkey" in the name was racist somehow. Including "monkey" in the name, however, could only be considered racist by people who equate monkeys with Africans or black persons, meaning that calling it monkey pox only sounds racist to racists.  

"So we want the Food and Drug Administration, the FDA, to approve our drug specifically for monkeypox and right now it's only considered experimental. And they won't approve it based on this study," Varma said.

He went on to say that the goal is to "spin" the study in media so that people "won't like dump the stock, thinking that the company is worthless."

"We want the Food and Drug Administration, the FDA, to approve our drug specifically for Monkeypox and right now it’s only considered experimental and they won’t approve it based on this study," Varma told his fake date, a Mug Club Investigations undercover reporter who posed as a love interest for Varma. 

"We also need to keep up the people’s belief that the [TPOXX] drug works. So, that’s why spinning it in the media is helpful," Varma said. His concern was making sure the company, and their drug, continued to seem viable. "You can spin them [TPOXX study results] so that people – won’t like, dump the stock thinking that the company is worthless," he said.

"Honestly," he told the undercover reporter, "in the United States, the risk [for Monkeypox] is very low. It’s only primarily transmitted among gay men. It basically got into the sexual networks of gay men, and a lot of gay men have tons and tons of sexual partners and often don’t use condoms. So as a result, it spreads more easily."

That it spread more easily in the gay community was another stigma the World Health Organization, and the CDC, were looking to avoid. So much so, that they have downplayed the risk among those who practice gay sex and attempted to make it seem like a broader threat to everyone. Varma admitted that "it's not going to spread among the general population, it's almost certainly going to stay primarily among gay men."
ADVERTISEMENT
ADVERTISEMENT
Sign in to comment

Comments

Powered by The Post Millennial CMS™ Comments

Join and support independent free thinkers!

We’re independent and can’t be cancelled. The establishment media is increasingly dedicated to divisive cancel culture, corporate wokeism, and political correctness, all while covering up corruption from the corridors of power. The need for fact-based journalism and thoughtful analysis has never been greater. When you support The Post Millennial, you support freedom of the press at a time when it's under direct attack. Join the ranks of independent, free thinkers by supporting us today for as little as $1.

Support The Post Millennial

Remind me next month

To find out what personal data we collect and how we use it, please visit our Privacy Policy

ADVERTISEMENT
ADVERTISEMENT
By signing up you agree to our Terms of Use and Privacy Policy
ADVERTISEMENT
© 2024 The Post Millennial, Privacy Policy | Do Not Sell My Personal Information